ResMed (RMD)
(Delayed Data from NYSE)
$240.71 USD
+0.20 (0.08%)
Updated Oct 14, 2024 04:00 PM ET
After-Market: $240.79 +0.08 (0.03%) 7:58 PM ET
2-Buy of 5 2
C Value B Growth D Momentum B VGM
Price, Consensus and EPS Surprise
RMD 240.71 +0.20(0.08%)
Will RMD be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for RMD based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for RMD
PHG or RMD: Which Is the Better Value Stock Right Now?
5 Dividend Growth Stocks to Buy in Q4
RMD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Zacks.com featured highlights Ferrari, Vertex, ResMed and Hubbel
ResMed (RMD) Upgraded to Buy: What Does It Mean for the Stock?
Scoop up These 4 GARP Stocks to Receive Handsome Returns
Other News for RMD
RMD Crosses Above Average Analyst Target
Resmed Officer Plans Stock Sale Worth $1.02 Million
ResMed CFO Executes Planned Stock Sale
Insider Sale: CFO Brett Sandercock Sells 1,000 Shares of ResMed Inc (RMD)
ResMed CEO Executes Pre-Planned Stock Trades